Purpose: We evaluated the outcomes of surgical intervention and active surveillance in patients diagnosed with cystic renal cell carcinoma at our hypothesized radiological cutoff of greater than 50% cystic. Materials and Methods: We identified all 430 patients with a pathologically confirmed cystic renal mass that fit our criteria from 2000 to 2015. The 292 patients with a lack of computerized tomography, tumors less than 50% cystic on imaging, multifocal tumors and prior renal cell carcinoma were excluded from study. Patients were stratified into benign or malignant subgroups, and radiological, clinicopathological and oncologic features were determined. Univariate and multivariate associations between clinicoradiological parameters in each group were analyzed. We similarly reviewed the records of a separate cohort of patients treated with active surveillance for cystic renal cell carcinoma. Results: Of the 138 identified cases of cystic renal cell carcinoma 102 (73.9%) were renal cell carcinoma and 36 (26.1%) were benign masses. Of the tumors 77.5% were Fuhrman grade 1-2, 83.4% were stage pT2 or less and 65.9% showed clear cell histology. On univariate analysis male gender, a solid component and increasing Bosniak classification were significant for malignancy. In a separate cohort we identified 38 patients on active surveillance. The growth rate was 1.0 mm per year overall and 2.3 mm per year for the solid component. At a median followup of more than 4 years in all cohorts there was no evidence of recurrence or metastasis of cystic renal cell carcinoma.
COMPLEX cystic renal masses have long posed a challenge to clinicians as they represent a heterogenous group of benign and malignant entities sharing overlapping clinical and radiological features. Currently the CT based Bosniak classification system remains the gold standard to predict the risk of malignancy in cystic renal masses, and guide management and counseling. 1 However, strict adherence to the Bosniak score in the absence of other diagnostic tools may lead to surgical overtreatment of many cystic lesions. 2 Emerging evidence suggests that AS is an acceptable initial management strategy in this population. 2e5 Thus, improved imaging criteria are required to help guide treatment algorithms for cystic renal masses and allow for increased implementation of AS protocols.
Historically cRCC has been the term to describe an indolent version of RCC composed predominantly of cysts. 6 The threshold of cystic involvement used to define cRCC has traditionally been greater than 75% cystic on pathological review. 7 However, this classification provides no contribution to preoperative decision making. Crosssectional imaging offers the benefit of assessing tumor morphology without surgical manipulation, allowing for accurate assessment of the solid and cystic components, and classification of cRCC. 3, 8 Recently groups evaluated radiological criteria for cRCC diagnosis, suggesting that cystic changes in 5% to 45% of the total mass on imaging are associated with favorable survival. 3, 8 Given the improved prognostic value that this cystic component yields, 8, 9 a consistent and more inclusive classification of cRCC is essential.
Therefore, we aimed to advance the preoperative assessment of cystic renal masses by evaluating cRCC as an enhancing renal lesion that is greater than 50% cystic on cross-sectional imaging. We propose that this classification, which is a simple approach that can easily be adapted into clinical practice, may yield an improved risk profile to allow for conservative treatment in carefully selected patients. The objective of our study was to compare the long-term outcomes of surgery and AS in patients with cRCC using this hypothesized threshold and identify any clinicoradiological parameters that may further predict the risk of malignancy.
MATERIALS AND METHODS

Cohorts
After institutional review board approval we queried the records of all 5,003 patients who underwent surgery for a renal mass from January 2000 to December 2015 using a prospectively maintained institutional database. All 430 masses that contained a cystic component on final pathology were identified. In this cohort we identified 138 cases that met our study inclusion criteria ( fig. 1) .
A separate cohort of 72 complex cystic masses initially managed by AS from January 2000 to December 2015 was also identified. AS protocols consisted of initial crosssectional imaging followed by US every 6 months for the first year with annual US studies used thereafter if no growth was present. US studies were included as part of our followup protocol but not for our radiological assessment. Our final AS cohort consisted of 38 cases ( fig. 1 ). Core biopsies were not done since they are known to have a low diagnostic yield in cystic renal masses. 10 
Radiological Review
CT images were rereviewed by 1 of 3 genitourinary radiologists (AMH, CD or OA) who were blinded to clinical and pathological characteristics. The solid component of the entire tumor was measured and visually graded into 4 groups, including none, less than 25%, 25% to 50% or greater than 50%. Additional imaging characteristics were also recorded, such as the Bosniak classification, maximal diameter in cm, tumor location (50% or greater exophytic, less than 50% exophytic and endophytic), and the presence of calcifications (yes or no), septations (yes or no) and other cysts (yes or no).
In our AS cohort we evaluated the growth rate of the entire lesion as calculated by the maximal diameter on the first and the last CT when available. In patients with a measurable solid component the growth rate of the solid component was also calculated.
Outcomes
Clinical, surgical, radiological, pathological 11 and postoperative outcomes were analyzed. Based on final pathology findings the patients were stratified into a RCC or a benign tumor subgroup. The benign subgroup consisted of the mixed epithelial and stromal tumor family, benign multilocular cysts and multilocular cystic renal neoplasms of low malignant potential. In a subset of patients with Bosniak 3 and 4 lesions associations between the percent of the solid component and the malignancy risk were similarly assessed. Followup was based on the last available CT.
Statistical Analysis
We evaluated univariate analyses of clinical, radiological and pathological parameters with the Fisher exact test and the Student t-test. For multivariate analysis we fitted a logistic model with 5 covariates (gender, Bosniak classification, solid component, solid percent and calcifications) that were significant on univariate analysis. Survival analyses were done using Kaplan-Meier curves and the log rank test. The prerejection threshold of all statistical tests was predefined at 0.05. All analyses were performed with R (https://www.r-project.org/). Of the patients on AS who underwent delayed surgical intervention AS was initially chosen due to favorable tumor characteristics on imaging in 63.6% and significant medical comorbidities in 54.5%. A change in tumor character in 45.4% of patients and patient preference to no longer remain on AS in 18.2% were noted as indications for surgery. On imaging 63.6% of lesions were Bosniak 4 with a solid component in 54.5%. On pathological review 63.6% of lesions were ccRCC, 54.5% were stage pT1 and 63.6% were Fuhrman grade 2 or less.
RESULTS Features
Surgery versus Active Surveillance. Table 2 When comparing patients who initially underwent surgery with those who were initially treated with AS followed by surgery, we found no significant difference between the proportion of tumors with malignant histology (p ¼ 0.9). Furthermore, we found no significant difference when looking at overall survival between those same subgroups (p ¼ 0.07). Overall no patient in our entire cohort died of kidney cancer. 
DISCUSSION
In this study we evaluated cRCC as a radiologically distinct subtype of RCC defined by an enhancing renal mass that was greater than 50% cystic on cross-sectional imaging. At this hypothesized threshold we found that a solitary cRCC in patients with no prior history of RCC had an excellent prognosis on AS and after surgical resection. The excellent prognosis of patients with cRCC compared to ccRCC was recognized in several previous reports, showing that this condition presents with less aggressive pathological features and carries a minimal risk of recurrence or metastasis following surgery. 3, 9 Our study included 5 patients (3%) with pT3 disease, as in a recent study in which 4% of the cohort had pT3 disease. 12 Even at higher stage and grade patients with cRCC have been shown to have better outcomes than those with ccRCC. 12 Given that these lesions are predominantly cystic, the solid portions of these tumors are often significantly smaller than the entire lesion. 3, 8 Median overall cRCC size in our cohort was 3.3 cm while the median solid component size was 0.8 cm. The solid portion is thought to contain the malignant components of these lesions so that the tumor burden is often significantly less than that of other tumors of similar size. 3, 8 Similar to other reports, ccRCC was the most common histology in our cohort, followed by tumors of benign etiology. 3, 13 Additionally, no patients presented with chromophobe RCC. 3, 8 However, 2 patients (1.6%) were diagnosed with unclassified RCC, which to our knowledge has not been documented previously in the literature. It is well established that it is difficult to differentiate benign and malignant complex cystic masses by current imaging techniques. Thus, any radiological definition of cRCC will also ultimately include benign tumors and other RCC subtypes.
In a recent study of the pathological and radiological correlates of complex renal cysts Reese et al found that the likelihood of malignancy increased with a rising Bosniak score and the presence of mural nodules. 14 We found a similar trend in our cohort. In addition, we observed that females with cRCC were more likely to have benign pathology (p ¼ 0.006), which remained true in our multivariate model (p ¼ 0.007). Because female gender is associated with a higher probability of benign renal neoplasms overall, 15 gender may need to be implemented in future diagnostic protocols for cRCC. However, further analyses must be performed.
Although it is well established that Bosniak 4 lesions carry an increased malignancy risk compared to Bosniak 3 lesions, 2 the Bosniak 4 classification did not reach statistical significance in our multivariate model. We attribute this discordant finding to the overlap between the defining criteria of Bosniak 4 lesions 2 and covariates indicating a solid component on imaging. Since a main criterion of categorizing a mass as Bosniak 4 is evidence of a solid component, 1,2 adding this covariate to the multivariate model results in an overlap of cases and consequent loss of the association between Bosniak score and malignancy.
In a recent study assessing the preoperative growth of cystic renal lesions Jhaveri et al found that 73% of tumors did not show a significant increase in size. 13 In a similar analysis of our AS cohort we noted that the median overall growth rate was 1.0 mm per year, in contrast to the mean growth rate of 2.8 mm per year in a meta-analysis of patients with solid renal tumors on AS. 16 Although we also noted that the solid portion growth rate was 2.3 mm per year, this was only found in 15 patients (39.5%) and may not be enough to appropriately quantify growth. Given the slow growth rate of cRCC and its more indolent nature, the radiological diagnosis of cRCC enables AS to be more confidently discussed with appropriately selected patients.
In patients who undergo surgery for a solitary Bosniak 3 or 4 cRCC partial nephrectomy is recommended when technically feasible. 4 Similarly 90% of the patients in our study underwent partial nephrectomy. 3, 9 followup care could be optimized, and less frequent and aggressive observation could be recommended postoperatively with reliance on simple chest imaging and renal US. This could potentially lower health care costs and reduce patient anxiety.
Although most patients with Bosniak 3 and 4 complex cystic renal masses undergo surgery, AS can be an acceptable initial approach. 4 Recent guidelines on the management of localized renal cancer state that AS can be initially implemented in patients with Bosniak 3 and 4 complex cystic lesions who have limited life expectancy, are at higher risk for surgical complications or have favorable tumor characteristics on imaging. 4, 20 Our data showed that initial management by AS followed by surgery was associated with no difference in the proportion of malignancy or overall survival compared to that in patients initially treated with surgery. Since cRCC lesions are smaller overall, have a smaller solid component and carry a lower oncologic risk than similar RCC masses, initial AS strategies should be considered. 9 There are several limitations to our study, including its retrospective design, limited followup and relatively small cohort. We chose to exclude patients with a history of RCC or other renal lesions to focus exclusively on solitary cystic masses. The cutoff that we implemented of greater than 50% cystic on imaging was hypothesis generated and must be validated in independent cohorts. We could not assess the growth rate in our original cRCC cohort because the majority did not have 2 preoperative CT scans available. In addition, given that patients on AS for cystic renal masses are often followed with serial US instead of CT, we could only assess the growth rate and radiological characteristics from the last available CT. We also could not comment on the incidence of these lesions since we identified our cohort by retrospective pathology review initially followed by radiological review. Therefore, any lesion that did not contain a cystic portion on pathology findings would not have been included in analysis.
CONCLUSIONS
Our data suggest that patients with unifocal cRCC evaluated using a standardized radiological threshold of greater than 50% cystic have an excellent prognosis on AS and postoperatively. In patients with serial imaging we also noted an interval growth rate of cRCC similar to that of solid renal tumors. We believe that our radiological definition allows for more inclusive criteria of cRCC and would encourage kidney sparing approaches or the implementation of AS protocols when feasible.
